213 related articles for article (PubMed ID: 30054435)
21. Mediator complex recruits epigenetic regulators via its two cyclin-dependent kinase subunits to repress transcription of immune response genes.
Tsutsui T; Fukasawa R; Shinmyouzu K; Nakagawa R; Tobe K; Tanaka A; Ohkuma Y
J Biol Chem; 2013 Jul; 288(29):20955-20965. PubMed ID: 23749998
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of the human PRMT5:MEP50 complex.
Antonysamy S; Bonday Z; Campbell RM; Doyle B; Druzina Z; Gheyi T; Han B; Jungheim LN; Qian Y; Rauch C; Russell M; Sauder JM; Wasserman SR; Weichert K; Willard FS; Zhang A; Emtage S
Proc Natl Acad Sci U S A; 2012 Oct; 109(44):17960-5. PubMed ID: 23071334
[TBL] [Abstract][Full Text] [Related]
23. OGG1 regulates the level of symmetric dimethylation of histone H4 arginine-3 by interacting with PRMT5.
Zhou X; Wang W; Du C; Yan F; Yang S; He K; Wang H; Zhao A
Mol Cell Probes; 2018 Apr; 38():19-24. PubMed ID: 29409673
[TBL] [Abstract][Full Text] [Related]
24. Protein arginine methyltransferase 5 (PRMT5) activates WNT/β-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3.
Shailesh H; Siveen KS; Sif S
J Cell Mol Med; 2021 Feb; 25(3):1583-1600. PubMed ID: 33462997
[TBL] [Abstract][Full Text] [Related]
25. CARM1-mediated methylation of protein arginine methyltransferase 5 represses human γ-globin gene expression in erythroleukemia cells.
Nie M; Wang Y; Guo C; Li X; Wang Y; Deng Y; Yao B; Gui T; Ma C; Liu M; Wang P; Wang R; Tan R; Fang M; Chen B; He Y; Huang DCS; Ju J; Zhao Q
J Biol Chem; 2018 Nov; 293(45):17454-17463. PubMed ID: 30257864
[TBL] [Abstract][Full Text] [Related]
26. The Structural Effects of Phosphorylation of Protein Arginine Methyltransferase 5 on Its Binding to Histone H4.
Börzsei R; Bayarsaikhan B; Zsidó BZ; Lontay B; Hetényi C
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232624
[TBL] [Abstract][Full Text] [Related]
27. Glutathionylation Decreases Methyltransferase Activity of PRMT5 and Inhibits Cell Proliferation.
Yi M; Ma Y; Chen Y; Liu C; Wang Q; Deng H
Mol Cell Proteomics; 2020 Nov; 19(11):1910-1920. PubMed ID: 32868396
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2
Ichikawa T; Suekane A; Nakahata S; Iha H; Shimoda K; Murakami T; Morishita K
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474089
[TBL] [Abstract][Full Text] [Related]
29. Structure of the arginine methyltransferase PRMT5-MEP50 reveals a mechanism for substrate specificity.
Ho MC; Wilczek C; Bonanno JB; Xing L; Seznec J; Matsui T; Carter LG; Onikubo T; Kumar PR; Chan MK; Brenowitz M; Cheng RH; Reimer U; Almo SC; Shechter D
PLoS One; 2013; 8(2):e57008. PubMed ID: 23451136
[TBL] [Abstract][Full Text] [Related]
30. The persistent organochlorine pesticide endosulfan modulates multiple epigenetic regulators with oncogenic potential in MCF-7 cells.
Ghosh K; Chatterjee B; Jayaprasad AG; Kanade SR
Sci Total Environ; 2018 May; 624():1612-1622. PubMed ID: 29054638
[TBL] [Abstract][Full Text] [Related]
31. Arginine methylation regulates IL-2 gene expression: a role for protein arginine methyltransferase 5 (PRMT5).
Richard S; Morel M; Cléroux P
Biochem J; 2005 May; 388(Pt 1):379-86. PubMed ID: 15654770
[TBL] [Abstract][Full Text] [Related]
32. Development of an AlphaLISA high throughput technique to screen for small molecule inhibitors targeting protein arginine methyltransferases.
Prabhu L; Chen L; Wei H; Demir Ö; Safa A; Zeng L; Amaro RE; O'Neil BH; Zhang ZY; Lu T
Mol Biosyst; 2017 Nov; 13(12):2509-2520. PubMed ID: 29099132
[TBL] [Abstract][Full Text] [Related]
33. Protein arginine methyltransferase Prmt5-Mep50 methylates histones H2A and H4 and the histone chaperone nucleoplasmin in Xenopus laevis eggs.
Wilczek C; Chitta R; Woo E; Shabanowitz J; Chait BT; Hunt DF; Shechter D
J Biol Chem; 2011 Dec; 286(49):42221-42231. PubMed ID: 22009756
[TBL] [Abstract][Full Text] [Related]
34. PRMT5 inhibition promotes osteogenic differentiation of mesenchymal stromal cells and represses basal interferon stimulated gene expression.
Kota SK; Roening C; Patel N; Kota SB; Baron R
Bone; 2018 Dec; 117():37-46. PubMed ID: 30189247
[TBL] [Abstract][Full Text] [Related]
35. Cryo-electron microscopy structure of a human PRMT5:MEP50 complex.
Timm DE; Bowman V; Madsen R; Rauch C
PLoS One; 2018; 13(3):e0193205. PubMed ID: 29518110
[TBL] [Abstract][Full Text] [Related]
36. PRMT5 confers lipid metabolism reprogramming, tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumours.
Yuan HF; Zhao M; Zhao LN; Yun HL; Yang G; Geng Y; Wang YF; Zheng W; Yuan Y; Song TQ; Niu JQ; Zhang XD
Acta Pharmacol Sin; 2022 Sep; 43(9):2373-2385. PubMed ID: 35046516
[TBL] [Abstract][Full Text] [Related]
37. Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.
Jing P; Zhao N; Ye M; Zhang Y; Zhang Z; Sun J; Wang Z; Zhang J; Gu Z
Cancer Lett; 2018 Jul; 427():38-48. PubMed ID: 29679612
[TBL] [Abstract][Full Text] [Related]
38. The arginine methyltransferase PRMT5 regulates CIITA-dependent MHC II transcription.
Fan Z; Kong X; Xia J; Wu X; Li H; Xu H; Fang M; Xu Y
Biochim Biophys Acta; 2016 May; 1859(5):687-96. PubMed ID: 26972221
[TBL] [Abstract][Full Text] [Related]
39. OXR1A, a Coactivator of PRMT5 Regulating Histone Arginine Methylation.
Yang M; Lin X; Segers F; Suganthan R; Hildrestrand GA; Rinholm JE; Aas PA; Sousa MML; Holm S; Bolstad N; Warren D; Berge RK; Johansen RF; Yndestad A; Kristiansen E; Klungland A; Luna L; Eide L; Halvorsen B; Aukrust P; Bjørås M
Cell Rep; 2020 Mar; 30(12):4165-4178.e7. PubMed ID: 32209476
[TBL] [Abstract][Full Text] [Related]
40. Interaction assessments of the first S-adenosylmethionine competitive inhibitor and the essential interacting partner methylosome protein 50 with protein arginine methyltransferase 5 by combined computational methods.
Zhu K; Jiang CS; Hu J; Liu X; Yan X; Tao H; Luo C; Zhang H
Biochem Biophys Res Commun; 2018 Jan; 495(1):721-727. PubMed ID: 29154828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
